Research Focus
The primary research focus of the Byrne Lab is to create new approaches that directly address the most important unmet needs in the field of gene therapy. The Byrne Lab develops gene therapies for retinal disease, including a diverse group of blinding disorders that have a profound impact on the quality of life of patients. The Byrne lab is exploring gene augmentation, optogenetics, and genome editing approaches to treat inherited and age-related forms of blindness.
